Sensei Biotherapeutics receives Nasdaq bid-price deficiency notice; 180 days to cure

Sensei Biotherapeutics, Inc.

Nasdaq notified Sensei on July 10, 2024 that common stock closed below $1.00 for 30 consecutive business days.
Company has until January 6, 2025 to regain compliance by closing at $1.00 or more for at least 10 consecutive days.
If not cured, may transfer to Nasdaq Capital Market with $5,000 fee and meet other listing standards.
Options to cure include potential reverse stock split; no assurance of maintaining listing.
Notice has no immediate impact on trading; Company will monitor and consider available remedies.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.